Maximus vs UrWay Health: Compare GLP-1 Programs & Pricing
Side-by-side Maximus and UrWay Health: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Maximus and UrWay Health are telehealth providers offering GLP-1–based weight management options. This comparison focuses on pricing signals that are publicly listed, clinical workflow, medication sourcing, and how each handles telehealth evaluations and follow-up. It is designed to help you quickly compare core differences before contacting a clinician.
Visit Maximus
Explore UrWay Health
Maximus vs UrWay Health: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Maximus | — | $132.99 | — | — No |
| UrWay Health | — | — | — | — No |
Maximus vs UrWay Health: Medical Process & Accessibility
Both Maximus and UrWay Health operate as telehealth programs that begin with an online intake and clinical review by a licensed medical provider. Standard practice for both includes a medical history, review of current medications, and evaluation of contraindications. Telehealth prescriptions are issued only after a clinician determines GLP-1 therapy is appropriate based on that evaluation and applicable state telemedicine laws.
Maximus vs UrWay Health: Pricing Comparison
Published pricing varies by product and formulation. For tirzepatide, Maximus lists a starting price of $132.99. Semaglutide pricing is not listed for either provider in the source data we have; if you need a quoted price, contact each provider directly since prescription strength, supply size, and pharmacy fulfillment can change costs.
Neither Maximus nor UrWay Health requires a membership fee according to available information, and promotional codes were not provided in the data set. Always confirm any first-order discounts or subscription models directly before enrolling, as occasional promos or package pricing can alter month-one costs.
Maximus vs UrWay Health: Clinical Oversight & Support
Both providers state that licensed clinicians manage treatment decisions and follow-up. Typical follow-up includes dose titration, monitoring for side effects, and periodic check-ins. UrWay Health emphasizes structured follow-ups and individualized dose adjustments; Maximus highlights quick intake and fast turnaround for approvals. In all cases, telehealth care should include an initial assessment and scheduled reassessments when prescribing GLP-1 medications.
Book a Consultation with Maximus
Maximus vs UrWay Health: Medication Quality & Safety
Both companies work with licensed U.S. pharmacies to dispense GLP-1 medications. Some offerings may be compounded alternatives rather than brand-name FDA-approved products like Wegovy® (semaglutide) or Mounjaro® (tirzepatide). Compounded formulations are legal when prescribed by a licensed clinician, but they are not FDA-approved brand formulations and may differ in manufacturing standards and labeling.
FDA guidance and state pharmacy laws govern telehealth prescribing. Patients should disclose all medical history, report side effects promptly, and follow clinician instructions for storage and administration. Providers must decline prescriptions if clinical contraindications exist.
Maximus vs UrWay Health: Customer Experience
Customer reports generally highlight Maximus for affordability and swift onboarding, while UrWay Health is noted for hands-on clinical communication and follow-up. Shipping timelines and pharmacy partners can vary; typical delivery occurs within about a week after a prescription is approved, though this depends on geographic location and pharmacy inventory.
Maximus vs UrWay Health: Final Verdict
Choose Maximus if a lower per-unit price for tirzepatide and a fast onboarding process are top priorities. Choose UrWay Health if you prefer a program that emphasizes scheduled follow-up and clinical engagement. Both are telehealth providers that rely on clinician assessment for safe prescribing and both work within U.S. pharmacy regulations.
Join Maximus
Get Started with UrWay Health
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Telehealth prescribing and use of GLP-1 therapies require evaluation by a licensed clinician. Branded FDA-approved drugs (for example, Wegovy® or Mounjaro®) differ from compounded alternatives. Always consult a licensed medical professional before beginning any medication regimen; compliance with state laws and FDA guidance is required. Affiliate links may earn the publisher a commission at no additional cost to you.